Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia.


Hematogenous candidiasis adds substantially to the morbidity and mortality rates of patients with cancer. Little is known about the risk factors and outcome in patients with breakthrough (BT) candidemia while on systemic antifungal therapy. All 479 episodes of candidemia in 474 consecutive patients with candidemia that was diagnosed at M. D. Anderson Cancer… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.